Baseline characteristics of study participants.
| Variable | Participants, n = 204 |
|---|---|
| Demographic characteristics | |
| Age, yrs, mean ± SD (range) | 40.0 ± 13.2 (19–73) |
| Female, n (%) | 189 (92.6) |
| Race, n (%) | |
| White | 77 (37.7) |
| Black | 61 (29.9) |
| Asian | 26 (12.8) |
| Other | 40 (19.6) |
| Ethnicity, n (%) | |
| Hispanic/Latino | 58 (28.4) |
| SLE characteristics | |
| SLE disease duration, yrs, mean ± SD (range) | 12.2 ± 8.8 (0–48) |
| PGA, 0–3, mean ± SD (range) | 0.8 ± 0.6 (0–2.8) |
| SELENA-SLEDAI, 0–105, mean ± SD (range) | 4.2 ± 3.5 (0–20) |
| Flare, n (%) | 40 (19.6) |
| SDI, 0–46, mean ± SD (range) | 1.2 ± 1.7 (0–8) |
SLE: systemic lupus erythematosus; PGA: physician’s global assessment; SELENA-SLEDAI: Safety of Estrogens in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.